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Abstract: New visnagin-9-sulfonamide derivatives 3 and 4a−c were synthesized through the reaction of visnagin-9-sulfonyl chloride 2 with amino 
compounds. Acetylation of compounds 4b and 4c gave the monoacetyl and diacetyl derivatives 5 and 6, respectively. Diazotization reaction of 
compound 4b afforded the corresponding benzotriazole derivative 8. Pyrazole and thiopyrimidine derivatives 9 and 10 were obtained via the 
opening of pyrone ring upon reaction of compound 3 with hydrazine hydrate and thiourea, respectively. In addition, hydrolysis of compound 3 
with potassium hydroxide furnished the visnaginone derivative 11 which used as starting material for synthesize benzofuran derivatives 12−14 
and bergaptene derivatives 15−17. The synthesized compounds were tested for antimicrobial activity. Furochromone derivatives 3, 4a−c, 5, 6 
and 8 (visnagin-9-sulfonamide derivatives) demonstrate moderate antibacterial and antifungal activities compared with the antibacterial and 
antifungal activites of the standard drugs. Benzofuran derivatives 11−14 (visnaginone derivatives) showed the lowest antimicrobial activity 
among all the compounds investigated in this study. Furocoumarin derivatives 15a,b, 16 and 17 (furobenzopyransulfonamide 
[bergaptensulfonamides]) are moderately active against all the tested strains. 
 





UE to the development of the bacterial resistant to 
many currently available antibiotic treatments, there 
is increasing interest in the discovery of new antimicro-
bial agents.[1–3] Visnagin (4-methoxy-7-methyl-5H-furo[3,2-
g] chromen-5-one) is one of the essential chemical constit-
uents of the fruits and seeds of Ammi visnaga, family Um-
belliferae and it is known to possess antispasmodic 
properties to the ureter and bile duct, treats angina, 
whooping cough, gall bladder and renal colic.[4] It is consid-
ered as a potent coronary vasodilator as well as its role in 
treating bronchial asthma.[5,6] Molecules with the chro-
mone scaffold possess wide range of biological activities, 
including antioxidant, antifungal, antimicrobial, antiallergenic, 
anti-inflammatory, antiproliferative and antitumor activi-
ties.[7–10] Chromones represent an attractive source of me-
dicinally interesting compounds due to their low toxicity. 
Many benzofurans are based on the chromone structure 
and they have been found to possess several therapeuti-
cally interesting biological activities.[11] Sulfonamides are 
bacteriostatic antimicrobial agents and they are most effec-
tive in early stages of acute infections when organisms mul-
tiply rapidly. Sulfonamide-based compounds were 
extensively used for antibacterial agents and they are the 
second antimicrobial agents.[12–14] These derivatives are still 
widely used today for the treatment of various bacterial, 
protozoal and fungal infections[15] and are the first effective 
chemotherapeutic agent used in safe therapeutic dosage 
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in continuation of our research program on the field of sul-
fonamide derivatives,[17–21] antimicrobial and antifungal 
agents,[22–25] we would like to report the synthesis of furo-
chromone, benzofuran and furocoumarin derivatives con-
taining sulfonamide moiety as a trial to obtain novel class 
of antibacterial and antifungal agents. 
 
RESULTS AND DISCUSSION 
Chemistry 
The starting material, visnagine-9-sulfonyl chloride 2[26] was 
prepared from the reaction of visnagine 1 with chlorosul-
fonic acid. The reactivity of sulfonylchloride derivative 2 to-
wards nitrogenous compounds was discussed. Thus, 
interaction of 2 with piperazine as secondary amine and  
o-phenatidine, o-phenylenediamine and 4,4’-diaminobi-
phenyl gave the corresponding sulfonamide derivatives 3 
and 4a−c, respectively (Scheme 1). The structures of 3 and 
4 have been assigned as a reaction product on the basis of 
analytical and spectral data. IR spectrum of 4a as an exam-
ple displayed absorption bands at 3239 and 1661 cm−1 due 
to NH and C=O functional groups, respectively. 1H NMR 
spectrum exhibited two sharp singlet signals at 2.40 ppm 
and 3.89 ppm assignable to CH3 and OCH3 protons, another 
triplet and quartet signals at 1.21 and 4.22 ppm specific for 
ethoxy protons. Other singlets were observed at 6.07 ppm 
corresponding for chromone-H proton, multiplet signals in 
6.69−7.95 ppm region owing to aroma c protons, two dou-
blets for furan protons as well as a broad signal at 8.61 ppm 
due to NH proton. Mass spectrum showed a molecular ion 
peak at m/z = 429, corresponding to a molecular formula 
C21H19NO7S.  
 Compounds 4b and 4c are considered as key inter-
mediates for the synthesis of some sulfonamide deriva-
tives. Thus, treatment of 4b and 4c with acetic anhydride 
produced the corresponding acetyl and diacetyl derivatives 
5 and 6, respectively (Scheme 2). Spectral data of the iso-
lated product was in complete agreement with the ex-
pected structures. IR spectrum of compound 6 showed 
absorption bands at 3121, 1710 and 1662 cm−1 correspond-
ing to NH and 2C=O functional groups, respectively. 1H 
NMR spectrum showed five singlet signals at 1.99, 2.32, 
4.06 and 6.19 ppm characteristic for 3CH3, OCH3 and chro-
mone-H protons, respectively. In addition, treatment of 4b 
with nitrous acid produced benzotriazole derivative 8 
through the formation of diazonium chloride salt 7 fol-
lowed by intramolecular cyclization via HCl elimination 
(Scheme 2). The structure of 8 was confirmed by elemental 
analysis and spectral data. IR spectrum exhibited band at 
1668 cm−1 corresponding for C=O group.  
 The reactivity of sulfonamide derivative 3 against bi-
nucleophilic reagents was investigated. Thus, treatment of 

























4a, R = 2-OC2H5
4b, R = 2-NH2
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in good yield a product that was identified as pyrazole de-
rivative 9. Formation of compound 9 is assumed to take 
place via nucleophilic attack of hydrazine which caused ring 
opening of -pyrone which readily undergo interamolecular 
cyclization by water elimination (Scheme 3). IR spectrum 
showed lack the band corresponding for carbonyl func-
tional group and showed broad band around 3392 cm−1 due 
to OH and NH functional groups. 1H NMR spectrum re-
vealed a singlet signal at 6.45 ppm characteristic for pyra-
zole proton also, another broad singlet signals at 10.41, 
11.14 ppm due to NH and OH protons. Similarly, interaction 
of 3 with thiourea in ethanol containing anhydrous potas-
sium carbonate led to ring opening. The thiopyrimidine de-
rivative 10 was assigned for the reaction product on the 
basis of its elemental analysis and spectral data obtained. 
IR spectrum lacked an absorption band due to a carbonyl 
functional group and revealed absorption bands at: 3443 
and 3221 cm−1 characteristic for OH and NH functional 
groups, respectively. 1H NMR spectrum displayed signals at 
7.34, 9.59 and 13.05 ppm assignable to pyrimidine-H, NH 
and OH protons, respectively. 
 It is interesting in this connection that the hydrolysis 
of sulfonamide derivative 3 with potassium hydroxide caused 
opening -pyrone ring and the product of this reaction was 
identified on the basis of its spectral data as visnaginone 
derivative 11. IR spectrum revealed the presence of OH and 
NH stretching bands at: 3165 and 3124 cm−1 and C=O band 
at: 1666 cm−1. Also, its 1H NMR spectrum supported its 
structure, as it revealed the piperazine ring protons at 
2.68−3.33 and two broad signals at 10.26 and 13.13 ppm 
assignable to NH and OH protons, respectively. Treatment of 
11 with dimethylformamide-dimethylacetal (DMF-DMA) in 
toluene under reflux afforded the corresponding enaminone 
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band around 3200 cm−1 due to OH and NH functions and at 
1668 cm−1 due to conjugated C=O functional group. Mass 
spectrum showed a molecular ion peak at m/z = 409, 
corresponding to a molecular formula C18H23N3O6S. In addi-
tion, condensation of visnaginone 11 with 4-chloroben-
zaldeyde gave the corresponding styryl derivative 13 which 
was condensed with phenylhydrazine to give the pyrazoline 
derivative 14 (Scheme 4). IR spectrum of compound 14 has 
no absorption band characteristic to C=O group and it re-
vealed the presence of C=N band at 1597 cm−1. 1H NMR 
spectrum showed the presence of signals corresponding for 
piperazine and pyrazoline protons in addition to the pres-
ence of two broad signals at: 9.36 and 14.17 for NH and OH, 
respectively. 
 In view of the growing biological importance of 
fuorocoumarin, particularly bergapten, it was of interest to 
synthesize some bergaptensulfonamides on the hope of 
obtaining more antimicrobial agents. Thus, cyclization of 11 
with malononitrile or ethyl cyanoacetate in the presence of 
piperidine afforded furobenzopyransulfonamide deriva-
tives 15a,b. Both elemental analysis and spectral data of 
the isolated products were in assignment with the pro-
posed structure. IR spectra of 15a,b showed bands around 
2200 cm−1 due to C≡N func onal group. Their 1H NMR spec-
tra exhibited two singlet signals around 2.42 and 4.10 ppm 
specific for CH3 and OCH3 protons. Interaction of 15b with 
elemental sulfur in ethanolic morpholine yielded thiophene 
derivative 16 via thiation of methyl group followed by in-
termolecular cyclization (Scheme 5). Its IR spectrum 
showed the disappearance of C≡N group and revealed 
bands at 3299 and 3414 cm−1 (NH2, NH). In addition, inter-
action of compound 15b with 4-methoxybenzylidene malo-
nonitrile furnished benzopergapten derivative 17. The 
formation of benzopergapten derivative 17 can be assumed 
via addition of methyl group in 15b to the activated double 
bond of arylidene to form intermediate. Cyclization of the 
latter intermediate formed another intermediate which 
subjected to elimination of HCN to form 17 (Scheme 5). 
Antibacterial and Antifungal Activities 
The synthesized compounds were tested in vitro for anti-
bacterial and antifungal activities by the agar diffusion 
method against the following strains: two Gram-positive 
bacteria, Staphylococcus aureus NCTC-7447 and Bacillus ce-
reus ATCC-14579; two Gram-negative bacteria, Pseudomo-
nas oeruginosa IMRU-70, and Esherichia coli NCTC-289; and 
three Fungi, Aspergillus ochraceus Wilhelm AUCC-230, Pen-
icillium chrysogenum thom AUCC-530 and Candida albicans 
AUCC-420. The results were summarized in Table 1. Most 
of the synthesized compounds exhibited various antimicro-
bial activity towards all the micro-organisms used. 
 Certain aspects of the structure activity relationships of 
the prepared compounds were clearly highlighted. The results 
of the antimicrobial screening demonstrated the following 
assumptions about the structural activity relationship (SAR). 
Incorporating piperazin-1-ylsulfonyl moiety in position 9  
of visnagine as in structure 3 had a detrimental effect  
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showed moderately active against all the tested strains. 
Changing the substituent on sulfonamide at position C-9 of 
visnagine from 2-ethoxyphenyl to 2-aminophenyl to 4-
aminobiphenyl (4a → 4b → 4c) to show the difference be-
tween each substituent on the effect of the antimicrobial 
activity was carried out. Compound 4c showed more activ-
ity than its analogues and showed high activities against all 
the tested strains. Incorporating sulfonamide-phenyl-acet-
amide moiety in position 9 of visnagine as in structure 5 did 
not improve the antimicrobial activity. Compound 5 
showed moderately active against all the tested strains. 
Similarly, incorporating sulfonamide-biphenyl-4-yl-acetam-
ide moiety in position 9 of visnagine as in structure 6 
showed little improvement on antimicrobial activity. Com-
pound 6 showed moderate activity against all the tested or-
ganisms. Surprising, incorporating 1H-benzo[d][1,2,3]triazol-
1-ylsulfonyl moiety in position 9 of visnagine as in structure 
8 did not showed remarkable improvement on the 
antimicrobial activity. Compound 8 showed moderately 
activity against all the tested bacteria and no activity 
against all the tested fungi. Broken -pyrone ring of 
visnagine as in structure 11 resulted in the lowest 
antimicrobial activity among all the investigated com-
pounds. Visnaginone derivative 11 showed no activity 
against most of the tested bacteria and fungi. Treatment of 
11 with dimethylformamide-dimethylacetal did not im-
prove the antimicrobial activity. Compound 12 showed no 
activity against most of the tested bacteria and fungi. In ad-
dition, condensation of visnaginone 11 with 4-chloroben-
zaldeyde did not improve the antimicrobial activity. Styryl 
derivative 13 showed no activity against most of the tested 
bacteria and fungi. Moreover, condensation of styryl deriv-
ative 13 with phenylhydrazine did not improve the antimi-
crobial activity. Pyrazole derivative 14 showed high activity 
against C. albicans only and no activity against most of the 
tested bacteria and fungi. Formation of fuorocoumarin (fu-
robenzopyransulfonamide [bergaptensulfonamides]) 
15a,b showed moderately active against all the tested 
strains. Treatment of 15b with sulfur or aryledine did not 
improve the antimicrobial activity. 
 
CONCLUSIONS 
Derivatives of furochromone, benzofuran and furocouma-
rin which bearing sulfonyl moiety were synthesized in order 
to evaluate their antibacterial and antifungal activities. Re-
garding the effect of each derivative against bacterial and 
fungal strains, results of antimicrobial activity in this study 
revealed that: Derivatives of visnagine with piperazin-1-yl-
sulfonyl moiety in position 9 showed moderate activity 
against all the tested strains. Changing the substituent at 
position C-9 of visnagine from N-(2-ethoxyphenyl)-sulfona-
mide to N-(2-aminophenyl)-sulfonamide or N-(4-aminobi-
phenyl)-sulfonamide improved the antimicrobial activity. 
Besides, N-(4-aminobiphenyl)-sulfonamide moiety showed 
higher activity against all the tested strains. Incorporating 
sulfonamide-phenyl-acetamide, sulfonamide-biphenyl-
4-yl-acetamide or 1H-benzo[d][1,2,3]triazol-1-ylsulfonyl 
moieties in position 9 of visnagine did not improve the 
antimicrobial activity. Broken -pyrone ring of visnagine 
Table 1. Antimicrobial activity of the synthesized compounds against the pathological organisms expressed as inhibition 
diameter zones in millimeters (mm) based on well diffusion assay 
Compd. No. 
Gram positive bacteria  Gram negative bacteria  Fungi 
S. aureus B. cereus P. aeruginosae E. coli A. o. wilhelm P. e. thom C. albicans 
3 5 10 6 12 13 5 0 
4a 12 13 17 19 6 12 13 
4b 13 15 16 18 14 14 6 
4c 14 18 19 20 19 18 5 
5 19 0 9 5 5 5 8 
6 9 8 8 10 18 10 9 
8 10 6 11 18 0 0 0 
11 5 0 0 0 0 8 3 
12 9 5 0 5 0 0 0 
13 4 8 5 5 4 0 5 
14 0 4 0 5 4 0 17 
15a 6 8 4 7 9 0 4 
15b 5 9 5 8 8 0 5 
16 8 5 8 9 8 0 0 
17 8 7 7 8 7 0 0 
Chloramphenicol 34 37 34 38 ------ ------ ------ 
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resulted in the lowest antimicrobial activity among all the 
compounds investigated in this study. Formation of 
fuorocoumarin (furobenzopyran-sulfonamide [bergapten-
sulfonamides]) showed moderate activity against all the 
tested strains.  
 
EXPERIMENTAL 
Melting points were determined on a digital Gallen-Kamp 
MFB-595 instrument and were uncorrected. IR spectra 
(KBr) were measured using a Jasco FT/IR-300E spectrome-
ter. 1H NMR were recorded on a Brucker (500 MHz) spec-
trometer using TMS as an internal standard; chemical shifts 
are reported as δ/ppm units. Mass spectra were performed 
on a Shimadzu GSMS-QP 1000 Ex mass spectrometer at 70 
eV. The elemental analyses were carried out at the Micro-
analytical Center, Cairo University, Cairo, Egypt. Antimicro-
bial screening was carried out in Biochemistry Department 
Faculty of Agriculture, Al-Azhar University. 
General Procedure for the Synthesis of 
Visnagin-9-sulfonamide Derivatives 3 
and 4a–c 
A mixture of 2 (0.01 mol), appropriate amines (namely; pi-
perazine, o-phenatidine, o-phenylenediamines and 4,4’-di-
aminobiphenyl) (0.01mol) and pyridine (1 mL) in dry 
benzene (25 mL) was heated under reflux for 2h, the sol-
vent was evaporated and the resulting solids were crystal-





White crystals; m.p. > 300 C; IR ṽ/cm–1: 3245 (NH), 1665 
(C=O); 1H NMR (DMSO-d6) δ/ppm: 2.56 (s, 3H, CH3), 2.74–
3.56 (m, 8H, piperazine moiety), 3.67 (s, 3H, OCH3), 6.45 (s, 
1H, pyrone), 6.92–7.80 (m, 2H, furan-H), 9.88 (br, 1H, NH, 
D2O-exchangeable); MS (m/z, %): 378 (M+, 54), 187 (100); 
Anal. Calcd. for C17H18N2O6S (378.40): C, 53.96; H, 4.79; N, 




Yellow sheets; m.p. 192–194 C; IR ṽ/cm–1: 3239 (NH), 1661 
(C=O); 1H NMR (CDCl3): δ/ppm: 1.21 (t, 3H, J = 6.85 Hz, CH3-
ethyl), 2.40 (s, 3H, CH3), 3.89 (s, 3H, OCH3), 4.22 (q, 2H, J = 
6.85 Hz, CH2-ethyl), 6.07 (s, 1H, H3-pyrone), 6.69–7.92 (m, 6H, 
4Ar-H + 2furan-H), 8.61 (br, 1H, NH; D2O-exchangeable); MS 
(m/z, %): 429 (M+, 38); Anal. Calcd. for C21H19NO7S (429.45): 




Yellow powder; m.p. 171–173 C; IR ṽ/cm–1: 3211, 3123 
(NH, NH2), 1673 (C=O); 1H NMR (CDCl3): δ/ppm: 2.42 (s, 3H, 
CH3), 3.94 (s, 3H, OCH3), 4.69 (br, 2H, NH2; cancelled with 
D2O); 6.11 (s, 1H, H3-pyrone), 6.55–7.72 (m, 6H, 4Ar-H + 
2furan-H), 9.61 (s, 1H, NH; D2O-exchangeable); MS (m/z, 
%): 400 (M+, 21), 229 (17), 201 (33), 107 (100); Anal. Calcd. 
for C19H16O6N2O6S (400.41): C, 56.99; H, 4.03; N, 7.00. 




Pink crystals; m.p. 240–242 C; IR ṽ/cm–1: 3238, 3173 (NH, 
NH2), 1663 (C=O); 1H NMR (DMSO-d6) δ/ppm: 2.39 (s, 3H, 
CH3), 4.01 (s, 3H, OCH3), 4.77 (br, 2H, NH2; D2O-exchangea-
ble); 6.17 (s, 1H, H3-pyrone), 6.55−7.70 (m, 10 H, 8Ar-H + 
2furan-H), 9.61 (s, 1H, NH; D2O-exchangeable); MS (m/z, 
%): 476 (M+, 34), 184 (100); Anal. Calcd. for C25H20N2O6S 
(476.50): C, 63.02; H, 4.23; N, 5.88. Found: C, 63.14; H, 4.31; 
N, 5.68. 
General Procedure for Acetylation of 
Compounds 4b and 4c 
The solution of 4b or 4c (0.01 mol) in acetic anhydride (10 
mL) was heated under reflux for 2h. The reaction mixture 
was cooled and the solid product collected and crystallized 




Yellow powder, the solid was crystallized from toluene; 
m.p. 186–188 C; IR ṽ/cm–1: 3271, 3160 (2NH), 1714, 1664 
(2 C=O); 1H NMR (DMSO-d6) δ/ppm: 2.22 (s, 3H, CH3), 2.52 
(s, 3H, CH3), 4.18 (s, 3H, OCH3), 6.09 (s, 1H, H3-pyrone), 
6.96–7.43 (m, 7H, 4Ar-H + 2furan-H + NH), 9.45 (br, 1H, NH, 
D2O-exchangeable); MS (m/z, %): 442 (M+, 43); Anal. Calcd. 
for C21H18N2O7S (442.44): C, 57.01; H, 4.10; N, 6.33. Found: 
C, 57.10; H, 4.20; N, 6.40. 
 
N-Acetyl-N-(4'-(4-methoxy-7-methyl-5-oxo-5H-furo[3,2-
g]chromene-9-sulfonamido) biphenyl-4-yl)acetamide (6) 
White crystals; the solid was crystallized from ethanol; 
m.p. 260–262 C; IR ṽ/cm–1: 3121 (NH), 1710, 1662 
(C=O); 1H NMR (DMSO-d6) δ/ppm: 1.99 (s, 3H, CH3), 2.32 
(s, 6H, 2COCH3), 4.06 (s, 3H, OCH3), 6.19 (s, 1H, H3-py-
rone), 7.25–8.24 (m, 11H, 8Ar-H + 2furan-H + NH); MS 
(m/z, %): 560 (M+, 51); Anal. Calcd. for C29H24N2O8S 
(560.58): C, 62.13; H, 4.32; N, 5.00. Found: C, 62.20; H, 
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A compound of 4b was dissolved in dil HCl (10 mL) then 
cooled to 0 C with stirring. A freshly solution of sodium ni-
trite (0.01 mol in 5 mL H2O) was gradually added. The solu-
tion was stirring for further 2h., then the solid that formed 
was filtered off and crystallized from ethanol as white crys-
tals; m.p. 150–151 C; IR ṽ/cm–1: 1668 (C=O); 1H NMR 
(CDCl3): δ/ppm: 2.15 (s, 3H, CH3), 3.87 (s, 3H, OCH3), 6.01 (s, 
1H, H3-pyrone), 7.19–8.11 (m, 6H, 4Ar-H + 2furan-H); MS 
(m/z, %): 411 (M+, 34); Anal. Calcd. for C19H13N3O6S 
(411.39): C, 55.47; H, 3.19; N, 10.21. Found: C, 55.60; H, 




A mixture of 3 (0.01 mol) and hydrazine hydrate (0.012 mol) 
in ethanol (30 mL) was heated under reflux for 3h, the re-
action mixture was cooled and the solid was collected and 
recrystallized from ethanol as yellow powder; m.p. 208–
210 C; IR ṽ/cm–1: 3392 (br, OH/ 2NH), 2949 (CH-aliph.), 
1598 (C=N); 1H NMR (DMSO-d6) δ/ppm: 2.56 (s, 3H, CH3), 
2.74–3.56 (m, 8H, piperazine moiety), 3.67 (s, 3H, OCH3), 
6.45 (s, 1H, pyrazole), 6.92–7.80 (m, 3H, 2furan-H + NH), 
10.41 (br, 1H, NH, D2O-exchangeable), 11.14 (br, 1H, OH; 
D2O-exchangeable); MS (m/z, %): 392 (M+, 61); Anal. Calcd. 
for C17H20N4O5S (392.43): C, 52.03; H, 5.14; N, 14.28. Found: 




A mixture of 3 (0.01 mol), thiourea (0.012 mol) and potas-
sium carbonate (0.5g) in ethanol (30 mL) was heated under 
reflux for 3h, the reaction mixture was cooled then acidified 
with dil. HCl. The solid product was collected and recrystal-
lized from ethanol to give 10 as yellow powder; m.p. 138–
140 C; IR ṽ/cm–1: 3443, 3221 (br, OH/ 2NH), 2925 (CH-al-
iph.), 1593 (C=N), 1280 (C=S); 1H NMR (DMSO-d6) δ/ppm: 
2.51 (s, 3H, CH3) 2.56–3.16 (m, 8H, piperazine), 3.41 (s, 3H, 
OCH3), 7.34 (s, 1H, pyrimidine), 7.41 (d, 1H, J = 2Hz, H3-fu-
ran), 7.97 (br, 1H, NH, D2O-exchangeable), 8.06 (d, 1H, J = 
2.2 Hz, H2-furan), 9.59 (br, 1H, NH, D2O-exchangeable), 
13.05 (br, 1H, OH, D2O-exchangeable); MS (m/z, %): 436 
(M+, 26); Anal. Calcd. for C18H20N4O5S2 (436.51): C, 49.53; H, 




A mixture of compound 3 (0.01 mol) and potassium hydrox-
ide (20%, 30 mL) was heated under reflux for about 4h., 
then cooled and poured into ice/ HCl. The obtained product 
was filtered off, washed several time with water and crys-
tallized from ethanol as white powder; m.p. > 300 C; IR 
ṽ/cm–1: 3165 (OH), 3124 (NH), 2922, 2841 (CH-aliph.), 1666 
(C=O); 1H NMR (DMSO-d6) δ/ppm: 2.58 (s, 3H, COCH3), 
2.68–3.33 (m, 8H, piperazine), 4.29 (s, 3H, OCH3), 7.50 (d, 
1H, J = 2.02 Hz, H3-furan) 7.81 (d, 1H, J = 2.01 Hz, H2-furan), 
10.26 (br, 1H, NH, D2O-exchangeable), 13.13 (br, 1H, OH, 
D2O-exchangeable); MS (m/z, %): 354 (M+, 41); Anal. Calcd. 
for C15H18N2O6S (354.38): C, 50.84; H, 5.12; N, 7.90. Found: 




A mixture of compound 11 (0.01 mol) and dimethylforma-
mide dimethylacetal (0.015 mol) in xylene (15 mL) was 
heated under reflux for 3h., the obtained product was fil-
tered off, washed with petroleum ether and crystallized 
from ethanol as yellow crystals; m.p. 149–150 C; IR ṽ/cm−1: 
3200 (br, NH/OH), 2926, 2846 (CH-aliph.), 1664 (C=O); 1H 
NMR (DMSO-d6) δ/ppm: 2.06 (s, 6H, 2CH3), 2.54–3.43 (m, 
8H, piperazine), 3.99 (s, 3H, OCH3), 6.78–7.81 (m, 4H, 
CH=CH + furan-H), 10.26 (br, 1H, NH, D2O-exchangeable), 
13.13 (br, 1H, OH, exchangeable with D2O); MS (m/z, %): 
409 (M+, 17.3), 51 (100); Anal. Calcd. for C18H23N3O6S 
(409.46) C, 52.80; H, 5.66; N, 10.26. Found: C, 52.71; H, 




A mixture of 11 (0.01 mol), 4-chlorobenzaldehyde and pi-
peridine (0.5 mL) in ethanol (30 mL) was heated under re-
flux for 4h. The solid obtained was collected and 
recrystallized from ethanol as a yellow powder; m.p. 178–
180 C; IR ṽ/cm–1: 3159 (br, NH/OH); 2954, 2823 (CH-aliph.), 
1660 (C=O); 1H NMR (CDCl3): δ/ppm: 2.66–3.18 (m, 8H, pi-
perazine), 3.91 (s, 3H, OCH3), 6.80–7.85 (m, 8H, CH=CH + 
4Ar-H + 2furan-H), 10.61 (br, 1H, NH, D2O-exchangeable), 
13.60 (br, 1H, OH, D2O-exchangeable); MS (m/z, %): 477 
(M+, 72); Anal. Calcd. for C22H21ClN2O6S (476.93): C, 55.40; 




A mixture of 13 (0.01 mol) and phenylhydrazine (0.01 mL) 
in ethanol (30 mL) was heated under reflux for 3h. The 
reaction mixture was cooled, the solid product was 
filtered off and crystallized from ethanol as a brown 
powder; m.p. 133–135 C; IR ṽ/cm–1: 3255 (br, NH/OH), 
2924, 2854 (CH-aliph.); 1H NMR (DMSO-d6) δ/ppm: 2.73–
3.58 (m, 10H, 8 piperazine-H + 2 pyrazoline-H), 4.00 (s, 3H, 
OCH3), 4.80 (d, 1H, pyrazoline-H), 6.77–8.55 (m, 11H, 9Ar-
H +2 furan-H), 9.36 (br, 1H, NH, D2O-exchangeable), 14.17 
(br, H, OH, D2O-exchangeable); MS (m/z, %): 567 (M+, 29); 
Anal. Calcd. for C28H27ClN4O5S (567.06) C, 59.31; H, 4.80; 
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General Procedure for the Synthesis of 
7-substitued furo[3,2-g] Chromen-6-car-
bonitrile Derivatives 15a,b 
A mixture of 14 (0.01 mol), malnonitrtile or ethyl cyanoace-
tate (0.0l mol) and piperidine (0.5mL) in ethanol (20 mL) 
was heated under reflux for 3h. The solid product was col-
lected and recrystallized from ethanol to give the corre-




Brown crystals; m.p. > 300 C; IR ṽ/cm–1: 3341, 3302 (2NH), 
2925 (CH-aliph.), 2196 (C≡N); 1H NMR (DMSO-d6) δ/ppm: 
2.44 (s, 3H, CH3), 2.78–3.54 (m, 8H, piperazine), 4.08 (s, 3H, 
OCH3), 6.77 (d, 1H, J = 2.0 Hz, furan-H3), 7.36 (br, 1H, NH, 
D2O-exchangeable), 7.94 (d, 1H, J = 2.1 Hz, furan-H2), 10.43 
(br, 1H, NH, D2O-exchangeable); MS (m/z, %): 402 (M+, 76); 
Anal. Calcd. for C18H18N4O5S (402.42) C, 53.72; H, 4.51; N, 




Brown needles; m.p. > 300 C; IR ṽ/cm–1: 3204 (NH), 2926 
(CH-aliph.), 2221 (C≡N), 1705 (C=O of α-pyrone); 1H NMR 
(DMSO-d6) δ/ppm: 2.42 (s, 3H, CH3), 3.30–3.51 (m, 8H, pi-
perazine), 3.94 (s, 3H, OCH3), 6.75 (d, 1H, J = 2.2 Hz, furan-
H3), 7.32 (br, 1H, NH, D2O-exchangeable), 7.94 (d, 1H, J = 
2.1 Hz, furan-H2); MS (m/z, %): 403 (M+, 28); Anal. Calcd. for 
C18H17N3O6S (403.41) C, 53.59; H, 4.25; N, 10.42. Found: C, 




A mixture of 15b (0.01 mol) and sulfur (0.01 mol) in ethanol 
(30 mL) containing triethylamine (0.5 mL) was heated un-
der reflux for 3h, the obtained solid was collected and crys-
tallized from ethanol as brown crystals; m.p. 119–120 C; IR 
ṽ/cm–1: 3414, 3299 (NH/NH2), 2987, 2927 (CH-aliph.), 1702 
(C=O of α-pyrone); 1H NMR (DMSO-d6) δ/ppm: 2.76−3.51 
(m, 8H, piperazine), 3.86 (s, 3H, OCH3), 6.75–7.94 (m, 5H, 2 
furan-H + thiophen-H + NH2), 9.32 (br, 1H, NH, D2O-ex-
changeable); MS (m/z, %): 435 (M+, 44); Anal. Calcd. for 
C18H17N3O6S2 (435.47) C, 49.65; H, 3.93; N, 9.65. Found: C, 





A mixture of 15b (0.01 mol), 4-methoxybenzylidene-malo-
nonitrile (0.01 mol) and piperidine (1 mL) in dimethyl 
formamide (20 mL) was heated under reflux for 4h. The 
product was filtered off and crystallized from ethanol as 
yellow crystals; m.p. 149–150 C; IR ṽ/cm–1: 3360, 3139 
(NH/NH2), 2928 (CH-aliph.), 2208 (C≡N), 1707 (C=O); 1H 
NMR (DMSO-d6) δ/ppm: 2.86–3.48 (m, 8H, piperazine), 
3.56 (s, 3H, OCH3), 3.78 (s, 3H, OCH3), 7.31–7.88 (m, 9H, 5 
Ar-H + 2 furan-H + NH2), 9.13 (br, 1H, NH, D2O-exchangea-
ble); MS (m/z, %): 560 (M+, 54); Anal. Calcd. for C28H24N4O7S 
(560.58) C, 59.99; H, 4.32; N, 9.99. Found: C, 59.73; H, 4.30; 
N, 9.80. 
Antimicrobial Assay 
The synthesized compounds were screened in vitro for 
their antimicrobial activities against strains of bacteria and 
strains of fungi by the agar diffusion technique.[1] A 1 
mg/mL solution in dimethylformamide was used. The bac-
teria and fungi were maintained on nutrient agar and 
Czapek's-Dox agar media, respectively. DMF showed no in-
hibition zones. The agar media were inoculated with differ-
ent microorganisms culture tested. After 24h of incubation 
at 37 °C for bacteria and 48h of incubation at 28 °C for fungi, 
the diameter of inhibition zone (mm) was measured. Chlo-
ramphenicol and Terbinafin used as references for antibac-
terial and antifungal activities, respectively. 
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